Journals / Turkish Journal of Gastroenterology / 2019 / Cilt: 30 - Sayı: 4

HLA-DQ2/DQ8 frequency in adult patients with celiac disease, their first-degree relatives, and normal population in Turkey

Pages
321–325
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

No statistically significant correlation was found between the HLA tissue groups and diarrhea(p=0.087), osteoporosis (p=0.215), anemia (p=1.000), tissue transglutaminase antibodies (p=0.295), anti-gliadin antibodies (p=0.104),and anti-endomysium antibodies (p=0.243) in the celiac patient group.Conclusion: HLA-DQ2/DQ8 can be used to diagnose celiac disease particularly when the tests are useless and to screen first-degreerelatives.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: Celiac disease is an autoimmune, familial disease that results in susceptibility to gluten in cereal and cereal productsin genetically susceptible individuals.
📊
Key Findings & Data:The aim of the present study was to investigate the presence of HLA-DQ2/DQ8 in patients withceliac disease, their first-degree relatives, and healthy community.Materials and Methods: HLA-DQ2/DQ8 analysis was performed in adult patients with celiac disease ≥18 years old (94 patients), theirfirst-degree relatives (89 people), and healthy group (102 individuals).
💡
Conclusion & Impact:No statistically significant correlation was found between the HLA tissue groups and diarrhea(p=0.087), osteoporosis (p=0.215), anemia (p=1.000), tissue transglutaminase antibodies (p=0.295), anti-gliadin antibodies (p=0.104),and anti-endomysium antibodies (p=0.243) in the celiac patient group.Conclusion: HLA-DQ2/DQ8 can be used to diagnose celiac disease particularly when the tests are useless and to screen first-degreerelatives.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: Celiac disease is an autoimmune, familial disease that results in susceptibility to gluten in cereal and cereal productsin genetically susceptible individuals. The aim of the present study was to investigate the presence of HLA-DQ2/DQ8 in patients withceliac disease, their first-degree relatives, and healthy community.Materials and Methods: HLA-DQ2/DQ8 analysis was performed in adult patients with celiac disease ≥18 years old (94 patients), theirfirst-degree relatives (89 people), and healthy group (102 individuals). Anemia, osteoporosis, and diarrhea were interrogated in the celiacpatient group and also anti-tissue transglutaminase, anti-endomysium, and anti-gliadin antibodies were recorded.Results: There was a significant relationship between HLA-DQ2/DQ8 presence in all groups, and the distribution of HLA-DQ2/DQ8in all groups was different (p=0.000). No statistically significant correlation was found between the HLA tissue groups and diarrhea(p=0.087), osteoporosis (p=0.215), anemia (p=1.000), tissue transglutaminase antibodies (p=0.295), anti-gliadin antibodies (p=0.104),and anti-endomysium antibodies (p=0.243) in the celiac patient group.Conclusion: HLA-DQ2/DQ8 can be used to diagnose celiac disease particularly when the tests are useless and to screen first-degreerelatives.

🔖

Cite This Article

ÖZGENEL, Ş. M., TEMEL, T., TEKE, H. Ü., YILDIZ, P., KORKMAZ, H., ÖZAKYOL, A. (2019). HLA-DQ2/DQ8 frequency in adult patients with celiac disease, their first-degree relatives, and normal population in Turkey. Turkish Journal of Gastroenterology, Cilt: 30 - Sayı: 4, 321–325. https://ajindex.com/articles/409287

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Yönal O, Özdil S. Çölyak hastalığı, Güncel Gastroenteroloji 2014, 18/1, 93-100.
  2. Biagi F, Klersy C, Balduzzi D, Corazza GR. Are we not over-estimating the prevalence of coeliac disease in the general population? Ann Med 2010; 42: 557-61. [CrossRef] Dalgic B, Sari S, Basturk B, et al. Turkish Celiac Study Group. Prevalence of celiac disease in healthy Turkish school children. Am J Gastroenterol 2011; 106: 1512-7. [CrossRef] Green PH, Cellier C. Celiac disease. N Engl J Med 2007; 357: 1731- 43. [CrossRef] Karell K, Louka AS, Moodie SJ, et al. European Genetics Cluster on Celiac Disease. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003; 64: 469- 77. [CrossRef] Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. Diagnosis and Management of Celiac Disease. Am J Gastroenterol 2013; 108:656-76. [CrossRef] Goddard AF, James MW, McIntyre AS, Scott BB. British Society of Gastroenterology. Guidelines for the management of iron deficiency anaemia. Gut 2011; 60: 1309-16. [CrossRef] Cosman F, Beur SJ, LeBoff MS, et al. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int 2014; 25: 2359- 81. [CrossRef] Reilly NR, Husby S, Sanders DS, Green PHR. Coeliac disease: to biopsy or not? Nat Rev Gastroenterol Hepatol 2017; 15: 60-6. [CrossRef] Holmes GKT, Hill PG. Coeliac disease: further evidence that biopsy is not always necessary for diagnosis. Eur J Gastroenterol Hepatol 2017; 29:1189-90. [CrossRef] Mubarak A, Wolters VM, Gerritsen SA, Gmelig-Meyling FH, Ten Kate FJ, Houwen RH. A biopsy is not always necessary to diagnose celiac disease. J Pediatr Gastroenterol Nutr 2011; 52: 554-7. [CrossRef] Shomaf M, Rashid M, Faydi D, Halawa A. Is the Diagnosis of Celiac Disease Possible Without Intestinal Biopsy? Balkan Med J 2017; 34: 313-7. [CrossRef] Basturk A, Artan R, Yilmaz A. The incidence of HLA-DQ2/DQ8 in Turkish children with celiac disease and a comparison of the geographical distribution of HLA-DQ. Prz Gastroenterol 2017; 12: 256- 61. [CrossRef] El-Akawi ZJ, Al-Hattab DM, Migdady MA. Frequency of HLADQA1*0501 and DQB1*0201 alleles in patients with coeliac disease, their first-degree relatives and controls in Jordan. Ann Trop Paediatr 2010; 30: 305-9. [CrossRef] Rostami-Nejad M, Romanos J, Rostami K, et al. Allele and haplotype frequencies for HLA-DQ in Iranian celiac disease patients. World J Gastroenterol 2014; 20: 6302-8. [Cr